Simcere Pharma sells stake in Shanghai Celgen Bio-Pharmaceutical for about $48 million
By The Associated Press | Associated Press – Tue, Jan 22, 2013 8:49 AM EST
Simcere Pharmaceutical Group has agreed to sell its stake in Shanghai Celgen Bio-Pharmaceutical Co. Ltd. for about 302 million yuan ($48.1 million).
The Chinese drug developer said Tuesday it entered into a share transfer agreement with Devont Asset Management Ltd. on Jan. 15 to sell its roughly 35 percent equity interest in Shanghai, which it acquired in 2009.
After the deal is completed, Simcere will no longer hold an equity interest in the company.
Simcere makes and sells pharmaceuticals in China, and focuses on the treatment of diseases that have high incidence or mortality rates like cancer, strokes or cardiovascular diseases.
Recent SCR News
- Strathcona Resources Ltd. Reports First Quarter 2024 Financial and Operating Results • PR Newswire (US) • 05/14/2024 10:35:00 PM
- Strathcona Resources Ltd. Reports First Quarter 2024 Financial and Operating Results • PR Newswire (Canada) • 05/14/2024 10:35:00 PM
- Strathcona Reports Voting Results from the 2024 Annual Meeting of Shareholders • PR Newswire (Canada) • 05/07/2024 06:13:00 PM
- Strathcona Reports Voting Results from the 2024 Annual Meeting of Shareholders • PR Newswire (US) • 05/07/2024 06:13:00 PM
- /C O R R E C T I O N from Source -- Strathcona Resources Ltd./ • PR Newswire (US) • 04/15/2024 10:35:00 PM
- Strathcona Announces Q1 2024 Conference Call • PR Newswire (Canada) • 04/15/2024 09:51:00 PM
- Strathcona Announces Q1 2024 Conference Call • PR Newswire (US) • 04/15/2024 09:51:00 PM
- Strathcona Resources Ltd. Reports Fourth Quarter and Full Year 2023 Financial and Operating Results • PR Newswire (US) • 03/26/2024 11:47:00 PM
- Strathcona Resources Ltd. Reports Fourth Quarter and Full Year 2023 Financial and Operating Results • PR Newswire (Canada) • 03/26/2024 11:47:00 PM
- Strathcona Resources Ltd. Reports Year End 2023 Reserves • PR Newswire (Canada) • 03/12/2024 02:07:00 AM
- Strathcona Resources Ltd. Reports Year End 2023 Reserves • PR Newswire (US) • 03/12/2024 02:07:00 AM
- Strathcona Announces Q4 2023 Conference Call • PR Newswire (US) • 02/08/2024 10:18:00 PM
- Strathcona Announces Q4 2023 Conference Call • PR Newswire (Canada) • 02/08/2024 10:18:00 PM
- Strathcona Resources Ltd. Reports Third Quarter 2023 Results and Announces 2023 and 2024 Guidance • PR Newswire (US) • 11/13/2023 11:30:00 PM
- Strathcona Resources Ltd. Reports Third Quarter 2023 Results and Announces 2023 and 2024 Guidance • PR Newswire (Canada) • 11/13/2023 11:30:00 PM
- Strathcona Resources Ltd. Announces Q3 2023 Conference Call • PR Newswire (US) • 10/19/2023 08:34:00 PM
- Strathcona Resources Ltd. Announces Q3 2023 Conference Call • PR Newswire (Canada) • 10/19/2023 08:34:00 PM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM